Chae Seung Yun, Kim Yaeni, Park Cheol Whee
Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, The College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.
Institute for Aging and Metabolic Disease, Seoul St. Mary's Hospital, The College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.
Antioxidants (Basel). 2023 Dec 6;12(12):2083. doi: 10.3390/antiox12122083.
Oxidative stress, a hallmark pathophysiological feature in diabetic kidney disease (DKD), arises from the intricate interplay between pro-oxidants and anti-oxidants. While hyperglycemia has been well established as a key contributor, lipotoxicity emerges as a significant instigator of oxidative stress. Lipotoxicity encompasses the accumulation of lipid intermediates, culminating in cellular dysfunction and cell death. However, the mechanisms underlying lipotoxic kidney injury in DKD still require further investigation. The key role of cell metabolism in the maintenance of cell viability and integrity in the kidney is of paramount importance to maintain proper renal function. Recently, dysfunction in energy metabolism, resulting from an imbalance in oxygen levels in the diabetic condition, may be the primary pathophysiologic pathway driving DKD. Therefore, we aim to shed light on the pivotal role of oxidative stress related to lipotoxicity and renal hypoxia in the initiation and progression of DKD. Multifaceted mechanisms underlying lipotoxicity, including oxidative stress with mitochondrial dysfunction, endoplasmic reticulum stress activated by the unfolded protein response pathway, pro-inflammation, and impaired autophagy, are delineated here. Also, we explore potential therapeutic interventions for DKD, targeting lipotoxicity- and hypoxia-induced oxidative stress. These interventions focus on ameliorating the molecular pathways of lipid accumulation within the kidney and enhancing renal metabolism in the face of lipid overload or ameliorating subsequent oxidative stress. This review highlights the significance of lipotoxicity, renal hypoxia-induced oxidative stress, and its potential for therapeutic intervention in DKD.
氧化应激是糖尿病肾病(DKD)的一个标志性病理生理特征,源于促氧化剂和抗氧化剂之间的复杂相互作用。虽然高血糖已被确认为一个关键因素,但脂毒性已成为氧化应激的一个重要诱因。脂毒性包括脂质中间体的积累,最终导致细胞功能障碍和细胞死亡。然而,DKD中脂毒性肾损伤的潜在机制仍需进一步研究。细胞代谢在维持肾脏细胞活力和完整性方面的关键作用对于维持正常肾功能至关重要。最近,糖尿病状态下氧水平失衡导致的能量代谢功能障碍可能是驱动DKD的主要病理生理途径。因此,我们旨在阐明与脂毒性和肾缺氧相关的氧化应激在DKD发生和发展中的关键作用。本文阐述了脂毒性的多方面机制,包括伴有线粒体功能障碍的氧化应激、由未折叠蛋白反应途径激活的内质网应激、促炎症反应和自噬受损。此外,我们探索针对脂毒性和缺氧诱导的氧化应激的DKD潜在治疗干预措施。这些干预措施侧重于改善肾脏内脂质积累的分子途径,并在面对脂质过载时增强肾脏代谢或改善随后的氧化应激。本综述强调了脂毒性、肾缺氧诱导的氧化应激及其在DKD治疗干预中的潜力的重要性。